One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine
A. Breslavsky (Ashkelon, Israel), A. Bar-Shai (Tel Aviv, Israel), N. Bilenko (Beer-Sheva, Israel), O. Wand (Ashkelon, Israel)
Source: International Congress 2022 – Diagnosis, prevention and management of infectious respiratory diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Breslavsky (Ashkelon, Israel), A. Bar-Shai (Tel Aviv, Israel), N. Bilenko (Beer-Sheva, Israel), O. Wand (Ashkelon, Israel). One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine. 2451
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|